ZA200205471B - Use of IL-18 inhibitors. - Google Patents

Use of IL-18 inhibitors.

Info

Publication number
ZA200205471B
ZA200205471B ZA200205471A ZA200205471A ZA200205471B ZA 200205471 B ZA200205471 B ZA 200205471B ZA 200205471 A ZA200205471 A ZA 200205471A ZA 200205471 A ZA200205471 A ZA 200205471A ZA 200205471 B ZA200205471 B ZA 200205471B
Authority
ZA
South Africa
Prior art keywords
inhibitors
Prior art date
Application number
ZA200205471A
Other languages
English (en)
Inventor
Yolande Chvatchko
Charles Dinarello
Christine Plater-Zyberk
Santer Van Deventer
Menachem Rubinstein
Daniela Novick
Soo-Hyun Kim
Original Assignee
Applied Research Systems
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems, Yeda Res & Dev filed Critical Applied Research Systems
Publication of ZA200205471B publication Critical patent/ZA200205471B/xx

Links

ZA200205471A 2000-02-21 2002-07-09 Use of IL-18 inhibitors. ZA200205471B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00103590 2000-02-21

Publications (1)

Publication Number Publication Date
ZA200205471B true ZA200205471B (en) 2003-10-29

Family

ID=30129156

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200205471A ZA200205471B (en) 2000-02-21 2002-07-09 Use of IL-18 inhibitors.

Country Status (5)

Country Link
CN (1) CN101062415A (xx)
ES (1) ES2365600T3 (xx)
TR (1) TR200502061T2 (xx)
UA (1) UA94022C2 (xx)
ZA (1) ZA200205471B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104474546A (zh) * 2010-08-13 2015-04-01 弗·哈夫曼-拉罗切有限公司 用于疾病治疗的针对IL-1β和IL-18的抗体
JOP20200308A1 (ar) * 2012-09-07 2017-06-16 Novartis Ag جزيئات إرتباط il-18
MY194040A (en) * 2015-03-05 2022-11-09 Ab2 Bio Sa Il-18 binding protein (il-18bp) and antibodies in inflammatory diseases

Also Published As

Publication number Publication date
TR200502061T2 (tr) 2005-08-22
ES2365600T3 (es) 2011-10-07
CN101062415A (zh) 2007-10-31
UA94022C2 (ru) 2011-04-11

Similar Documents

Publication Publication Date Title
GB0025782D0 (en) Use of inhibitors
HUP0300061A3 (en) Use of il-18 inhibitors
AU8212901A (en) Deacetylase inhibitors
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
IL157656A0 (en) Metalloproteinase inhibitors
IL157570A0 (en) Metalloproteinase inhibitors
AU4344101A (en) Protease inhibitors
EP1324759A4 (en) NF - G (K) B INHIBITORS
IL157658A0 (en) Metalloproteinase inhibitors
MXPA03000694A (es) Nuevo uso de los inhibidores de lipasa.
AU4217201A (en) Tri-aryl-substituted-ethane pde4 inhibitors
EP1307204A4 (en) PROTEASES INHIBITORS
IL131047A0 (en) Use of il-18 inhibitors
EP1278502A4 (en) PROTEASE INHIBITORS
ZA200205471B (en) Use of IL-18 inhibitors.
IL160230A0 (en) Use of il-18 inhibitors
HUP0301964A3 (en) Protease inhibitors
AU2002221882A1 (en) Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors
GB0021193D0 (en) Inhibitors
GB0029733D0 (en) Inhibitors
GB0029730D0 (en) Inhibitors
GB0015996D0 (en) Inhibitors
IL147675A0 (en) Use of il-18 inhibitors
GB0101135D0 (en) Inhibitors
GB0101134D0 (en) Inhibitors